ea0066p72 | Pituitary | BSPED2019
Juliusson Petur
, Dahlgren Jovanna
, Abuzzahab Jennifer
, Blair Jo
, Pietropoli Alberto
, Romano Alicia
Objective: To describe real-world safety data on growth hormone therapy (GHT) in paediatric patients with Noonan syndrome (NS) who were enrolled in NordiNet® IOS and the ANSWER®Program.Introduction: Patients with NS have a high prevalence of cardiac defects and an increased risk for leukaemia and certain malignancies compared to the general population. Current safety data do not indicate an association of GHT with worsenin...